Cephalexin Hydrochloride

Sold as Keftab. Every FDA application for this active ingredient.

As of Nov 15, 2026, FDA lists 1 application for Cephalexin Hydrochloride (sold as Keftab), first approved Oct 29, 1987, with 0 new uses approved and 0 published complete response letters.

First approved: Oct 29, 1987
Applications: 1
New uses approved: 0
Complete response letters: 0

What Pharmacies Pay

Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change

CEPHALEXIN 125 MG/5 ML SUSP: $0.059 per MLGeneric · -19% in a year
CEPHALEXIN 250 MG CAPSULE: $0.090 per unitGeneric · -7% in a year
CEPHALEXIN 250 MG TABLET: $0.717 per unitGeneric · -23% in a year
CEPHALEXIN 250 MG/5 ML SUSP: $0.059 per MLGeneric · -13% in a year
CEPHALEXIN 500 MG CAPSULE: $0.117 per unitGeneric · -9% in a year
CEPHALEXIN 500 MG TABLET: $1.31 per unitGeneric · -11% in a year
CEPHALEXIN 750 MG CAPSULE: $5.27 per unitGeneric · -16% in a year

Clinical Trials

22 open or ongoing studies name this ingredient as an intervention, including as a comparator; newest first. See all


Effects of Hypoxia or Caffeine on 4km Time-trial Morning Cycling.Caffeine, Hypoxia · Liverpool John Moores University	Phase 4	Recruiting	Nov 13, 2026
Precision Management of Urinary Tract Symptoms in Older WomenUrinary Tract Infection (Diagnosis) · Megan Bradley	Phase 3	Recruiting	Jul 7, 2026
Naproxen Versus Placebo as Adjunct Treatment of CellulitisCellulitis, Skin Disease, Infectious · Ottawa Hospital Research Institute	Phase 3	Not yet recruiting	Jun 24, 2026
Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsOveractive Bladder · The Cleveland Clinic	Early phase 1	Recruiting	Jun 15, 2026
Extended Oral Antibiotic Prophylaxis in Diabetic Fracture PatientsFracture Lower Leg, Diabetes · Texas Tech University Health Sciences Center, El Paso	Phase 4	Recruiting	May 1, 2026
Prophylactic Antibiotics for Outpatient Urethral BulkingUrinary Tract Infections, Stress Urinary Incontinence · University of Miami	Phase 4	Recruiting	Mar 30, 2026
Benson Relaxation Technique Effectiveness on Pain and Quality of Life Post Reconstructive MammoplastyBreast Cancer · Cairo University	Not applicable	Not yet recruiting	Jun 24, 2025
A Platform Trial for Gram Negative Bloodstream InfectionsGram-negative Bacteremia · Sunnybrook Health Sciences Centre	Not applicable	Recruiting	Aug 5, 2024

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Oct 29, 1987	KeftabNDA 50614 · New dosage form	Lilly	13	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA